Health Condition 1: D67- Hereditary factor IX deficiency Health Condition 2: D66- Hereditary factor VIII deficiency
Conditions
Interventions
Intervention1: Immunogenicity of Hepatitis B vaccine given intradermal: Recombinent Hepatitis B booster vaccine 2mcg will be given by intradermal route.
Control Intervention1: immunogenicity of hepat
Sponsors
University College of Medical Sciences and Guru Teg Bahadur Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Evidence of Hepatitis B vaccination (documentary / recall) Anti HBs antibody titres less than 10 mIU/ml will be included
Exclusion criteria
Exclusion criteria: Immunocompromised condition like HIV or individuals on steroids Known case of chronic liver disease or chronic kidney disease Hepatitis B surface antigen postitive Hepatitis B core antigen postitive (IgG)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of seroprotective individuals that is anti HBs titres more than 10 mIU per ml in both the groups at 1 month n 7 month of booster vaccinationTimepoint: 1 month n 7 months of booster vaccination | — |
Secondary
| Measure | Time frame |
|---|---|
| Level of anti HBs antibody titres at 1 month and 7 months of booster vaccination.Timepoint: 1 month and 7 months of vaccination;Proportion of individuals with severe local reaction like local hematoma, scarring ,nodule, pain, itching or systemic reactions like anaphylaxis.Timepoint: within 7 months of vaccination | — |
Countries
India
Contacts
Public ContactDr Sunil Gomber
University College Of Medical Sciences GTB hospital New Delhi
Outcome results
None listed